DRRX: Nilai perusahaan marang bathi resik DURECT

Simbol lan logo merek DURECT (DRRX)

This daily price chart for DURECT Corporation (DRRX) on the GURU.Markets platform tracks the company developing epigenetic therapies for severe liver damage, where the indicator stands at -4.10. Business revenues will be based on insurance payouts for innovative injections that reduce patient mortality. The project's ultimate success relies on the results of Phase 3 larsucosterol trials and the robustness of the patent portfolio.

DRRX - Pangali P/E DURECT ing rentang 04.07.2022 - 27.09.2025

Rincian metrik komprehensif lan analitis DURECT Corp (DRRX)

- rega lan prakiraan konsensus rega:
Rega saham DURECT Corp.|DRRX - Target konsensus
- informasi kapitalisasi pasar:
Nilai pasar DURECT Corporation|DRRX - Nilai Total Perusahaan
- indikator nilai aset resik miturut neraca:
Aset Bersih saben Siji Saham DURECT|DRRX - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku durect.com|DRRX - Gunggung Aset Perusahaan
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas DURECT Corporation|DRRX - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal DURECT Corp.|DRRX - Utang perusahaan|Rasio utang marang aset resik DURECT Corporation|DRRX - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan DURECT|Rasio cepet durect.com
- statistik bathi lan rasio pasar:
DRRX - Bathi resik perusahaan|Penghasilan resik sing dikarepake DURECT Corporation|DRRX - Pangali P/E|Rasio prakiraan rega marang bathi DURECT Corp.|DRRX - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan DURECT Corporation|DRRX - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan DURECT|DRRX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan durect.com|DRRX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep DURECT Corporation
- statistik dodolan lan pendapatan perusahaan:
DRRX - Pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan DURECT Corp.|DRRX - Rasio rega marang pendapatan|Rega forward marang dodolan DURECT Corporation
Analisis komprehensif perusahaan:durect.com - DRRX
Produk merek DURECT

The P/E ratio determines the market value of a business relative to its annual net income, measuring the investment payback period assuming a constant level of earnings. For DURECT Corporation (DRRX), the price-to-earnings ratio trend reflects market confidence in the monetization of robotic bio-screening and AI platforms, allowing for an assessment of the premium the market currently prices into the efficiency of automated drug development within the current share price.

Pesaing wigati

Pangali P/E arrowheadpharma.com|Koefisien rega marang bathi MIRM (Mirum)|DVAX (Dynavax Technologies) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Arbutus ABUS|Inventiva Corp - Rasio rega marang bathi|Gyre Therapeutics, Inc. - Pangali P/E|Periode bali modal bisnis assemblybio.com ASMB|GALT (galectintherapeutics.com) - Koefisien rega marang bathi|GNFT (GENFIT) - Rasio rega marang bathi|ALGS (Aligos Therapeutics Inc.) - Pangali P/E|Kapitalisasi marang bathi BioVie Pharma BIVI|Rasio rega marang bathi Galmed Pharmaceuticals (GLMD)|NDRA (endrainc.com) - Nilai perusahaan marang bathi resik|Pangali P/E HEPA (Hepion Pharmaceuticals, Inc.)